Uraemic pruritus--new perspectives and insights from recent trials.
about
Interventions for itch in people with advanced chronic kidney diseasePharmacological interventions for pruritus in adult palliative care patientsNew insights into the pathophysiology and treatment of chronic itch in patients with end-stage renal disease, chronic liver disease, and lymphomaPruritus in hemodialysis patients.Epidemiology of uraemic itch: New data.Prevalence, Pattern and Association of Pruritus with Quality of Life in Chronic Kidney Disease Patients Attending Kidney Care Centre, Ondo City, Southwest Nigeria.Blood lead level is a positive predictor of uremic pruritus in patients undergoing hemodialysisSericin cream reduces pruritus in hemodialysis patients: a randomized, double-blind, placebo-controlled experimental studyPharmacological interventions for pruritus in adult palliative care patients.Efficacy of omega-3 fatty acids supplementation in treatment of uremic pruritus in hemodialysis patients: a double-blind randomized controlled trial.Effect of different synthetic membranes on laboratory parameters and survival in chronic haemodialysis patientsSubstance P and intensity of pruritus in hemodialysis and peritoneal dialysis patientsTherapeutic Effects of Omega-3 Fatty Acids on Chronic Kidney Disease-Associated Pruritus: a Literature Review.Nalfurafine hydrochloride for the treatment of pruritus.Aberrant function and differentiation of monocytes in end stage renal disease.Pruritus in Kidney Disease.Pruritus as a leading symptom: clinical characteristics and quality of life in German and Ugandan patients.Pruritus in hemodialysis patients: Results from the Japanese Dialysis Outcomes and Practice Patterns Study (JDOPPS).Uremic pruritus, cytokines, and polymethylmethacrylate artificial kidney.Epidemiology and determinants of pruritus in pre-dialysis chronic kidney disease patients.Possible clinical effects of molecular hydrogen (H2) delivery during hemodialysis in chronic dialysis patients: Interim analysis in a 12 month observation.Evaluating the association between alterations in mineral metabolism and pruritus in hemodialysis patients.Hyperosmolar solutions selectively block action potentials in rat myelinated sensory fibers: implications for diabetic neuropathy.Gabapentin and uremic pruritus in hemodialysis patients.Self-reported symptoms in patients on hemodialysis with moderate to severe secondary hyperparathyroidism receiving combined therapy with cinacalcet and low-dose vitamin D sterols.Comparison of pregabalin with doxepin in the management of uremic pruritus: a randomized single blind clinical trial.Cutaneuos findings in patients with predialysis chronic kidney disease.Effect of a novel kappa-receptor agonist, nalfurafine hydrochloride, on severe itch in 337 haemodialysis patients: a Phase III, randomized, double-blind, placebo-controlled study.Self-reported subjective sleep quality and fatigue in patients with peritoneal dialysis treatment at home.Effect of hemodialysis fluid cooling uremic pruritus in hemodialysis patients.
P2860
Q24188168-DD50321C-F9F5-4C5A-B4C9-581D917739F9Q24202000-69DA2387-9F87-4CF8-A65A-4B4B60A2C8A5Q24615751-2D8B7D0A-92D0-4EEE-8D2C-46AF52DF351EQ24811870-E3FA66F2-0788-4E2A-986C-15DBE42E0DB1Q30998773-2BEC4C5C-7B8C-4615-9B29-DE11D0B7C585Q33556151-719B7C62-F5DD-4D01-8610-61A223142E6DQ33813231-0F77AB9B-45DA-4184-B69A-2FDC55066355Q34420464-CC95917B-DDF3-47C1-A45D-149C568775CBQ36193800-EB2B3A9E-B7E7-4A15-9F33-3DD5D88D0A22Q36350869-14B51E74-2F8F-43FA-B19A-EBC2CCF89D1BQ36745402-3FAD7E93-FF9C-46DC-865E-7D9BC2ADBD9FQ37157513-58F9A51E-4C6A-4E3C-A333-7496510B26CAQ37590722-B0DDFD20-9060-4748-B937-B3C7224D3E9DQ38015897-335636CE-BDE9-48AC-8F8D-3E7E01C53D38Q38053322-D3C88AA4-B811-4FB7-8DA7-2B7D4D049720Q38583951-6CDD1AD9-2BA6-4F45-9B92-12D1284641ECQ38878966-04595888-67AF-4957-9E58-A789D656CC76Q39207931-16BA31A3-01F4-4DAE-AE0A-5E8E3B865B9CQ39320846-754F03CE-775D-4AE3-86B3-1F5F47188BC9Q40112220-C7912320-37B6-4774-8270-1E3281184B53Q41141288-A92A0E08-CD3F-41F7-872E-7CE84819610DQ43958355-6ED3B59A-320D-4674-9E17-8FA9F551F47CQ44588607-00C91F5B-DCE2-45A3-87D5-2DE0AAB7FECDQ46124053-6D976209-1370-4292-A09A-F5402ED08A5FQ46305757-6B6C597A-A774-4957-832B-4B09B3B7A4A4Q47701692-FD3BCD4A-27FE-41DD-A6E7-EDDD65C042EFQ47841918-70AAEE28-92B2-46D7-AA14-7FD20EECFFBEQ48381465-9677E071-A2CD-4215-803F-9FD5BD3413F0Q48502288-FA9E4EF8-F15D-4C45-B7D5-73F3C10E9238Q54968732-5D018395-7452-4E11-9C2E-01494B280CB3
P2860
Uraemic pruritus--new perspectives and insights from recent trials.
description
2002 nî lūn-bûn
@nan
2002 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Uraemic pruritus--new perspectives and insights from recent trials.
@ast
Uraemic pruritus--new perspectives and insights from recent trials.
@en
Uraemic pruritus--new perspectives and insights from recent trials.
@nl
type
label
Uraemic pruritus--new perspectives and insights from recent trials.
@ast
Uraemic pruritus--new perspectives and insights from recent trials.
@en
Uraemic pruritus--new perspectives and insights from recent trials.
@nl
prefLabel
Uraemic pruritus--new perspectives and insights from recent trials.
@ast
Uraemic pruritus--new perspectives and insights from recent trials.
@en
Uraemic pruritus--new perspectives and insights from recent trials.
@nl
P2093
P356
P1476
Uraemic pruritus--new perspectives and insights from recent trials.
@en
P2093
Christiane Pauli-Magnus
Dominik Mark Alscher
Thomas Mettang
P304
P356
10.1093/NDT/17.9.1558
P407
P577
2002-09-01T00:00:00Z